Viridian Therapeutics Ors Inc (VRDN)
R&D Expenses
$71.58M
Quarterly · Period ending: · USD
VRDN R&D Expenses
Latest reported$71.58Mperiod ending
Latest reported$71.58Mperiod ending
VRDN Quarterly R&D Expenses ($45.74K → $71.58M)
Quarterly R&D Expenses
High-resolution chart · PNG
VRDN r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 71,577,000 | |
| 77,631,000 | |
| 89,207,000 | |
| 86,261,000 | |
| 86,626,000 | |
| 76,835,000 | |
| 71,960,000 | |
| 69,158,000 | |
| 56,193,000 | |
| 40,944,000 | |
| 38,557,000 | |
| 30,385,000 | |
| 40,083,000 | |
| 50,740,000 | |
| 39,317,000 | |
| 22,119,000 | |
| 21,712,000 | |
| 17,746,000 | |
| 22,394,000 | |
| 8,121,000 | |
| 12,565,000 | |
| 13,806,000 | |
| 15,254,000 | |
| 3,111,000 | |
| 3,836,000 | |
| 6,103,000 | |
| 8,417,000 | |
| 9,027,000 | |
| 8,599,000 | |
| 8,751,000 | |
| 8,234,000 | |
| 7,399,000 | |
| 8,375,000 | |
| 6,413,000 | |
| 4,998,000 | |
| 5,018,000 | |
| 5,487,000 | |
| 4,120,000 | |
| 21,000 | |
| 226,000 | |
| 334,000 | |
| 307,000 | |
| 456,000 | |
| 253,000 | |
| 194,000 | |
| 100,000 | |
| 144,712 | |
| 76,214 | |
| 9,023 | |
| 8,707 | |
| -85,346 | |
| 46,604 | |
| 22,820 | |
| 45,743 |